Gane, Edward J <br/><br/>
Efficacy of Ledipasvir Plus Sofosbuvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2 Infection.  [electronic resource] 

 -  Gastroenterology  05 2017 
 - 1366-1371 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-0012 
<br/><br/><label>Standard No.: </label>10.1053/j.gastro.2017.01.017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antiviral Agents--administration & dosage<br/>Benzimidazoles--administration & dosage<br/>Drug Combinations<br/>Fatigue--chemically induced<br/>Female<br/>Fluorenes--administration & dosage<br/>Genotype<br/>Headache--chemically induced<br/>Hepacivirus--genetics<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Male<br/>Middle Aged<br/>Nausea--chemically induced<br/>Sofosbuvir--administration & dosage<br/>Sustained Virologic Response